Search and Browse
Download
Enter Data
BDBM5026 3-substituted thiazolidene deriv. 17a::N-[(2Z)-5-tert-butyl-3,4-dimethyl-2,3-dihydro-1,3-thiazol-2-ylidene]-3-nitrobenzene-1-sulfonamide::thiazolidenebenzenesulfonamide deriv. 1
SMILES: Cc1c(s\c(=N/S(=O)(=O)c2cccc(c2)[N+]([O-])=O)n1C)C(C)(C)C
InChI Key: InChIKey=DVJYFYQACAKCOT-PEZBUJJGSA-N
Data: 8 IC50
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HIV-1 Reverse Transcriptase (Human immunodeficiency virus type 1) | BDBM5026 (3-substituted thiazolidene deriv. 17a | N-[(2Z)-5-...) | PDB MMDB B.MOAD GoogleScholar AffyNet  | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 270 | n/a | n/a | n/a | n/a | 8.4 | 37 |
Yamanouchi Pharmaceutical Co. Ltd | Assay Description The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro. | Bioorg Med Chem 13: 949-61 (2005) Article DOI: 10.1016/j.bmc.2004.11.045 BindingDB Entry DOI: 10.7270/Q2C53J1Z | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| HIV-1 Reverse Transcriptase Mutant (K103N) (Human immunodeficiency virus type 1) | BDBM5026 (3-substituted thiazolidene deriv. 17a | N-[(2Z)-5-...) | PDB MMDB B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 1.30E+4 | n/a | n/a | n/a | n/a | 8.4 | 37 |
Yamanouchi Pharmaceutical Co. Ltd | Assay Description The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro. | Bioorg Med Chem 13: 949-61 (2005) Article DOI: 10.1016/j.bmc.2004.11.045 BindingDB Entry DOI: 10.7270/Q2C53J1Z | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| HIV-1 Reverse Transcriptase Mutant (Y181C) (Human immunodeficiency virus type 1) | BDBM5026 (3-substituted thiazolidene deriv. 17a | N-[(2Z)-5-...) | PDB MMDB B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 66 | n/a | n/a | n/a | n/a | 8.4 | 37 |
Yamanouchi Pharmaceutical Co. Ltd | Assay Description The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro. | Bioorg Med Chem 13: 949-61 (2005) Article DOI: 10.1016/j.bmc.2004.11.045 BindingDB Entry DOI: 10.7270/Q2C53J1Z | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Reverse Transcriptase (Human immunodeficiency virus 1) | BDBM5026 (3-substituted thiazolidene deriv. 17a | N-[(2Z)-5-...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 1.29E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Korea Institute of Science and Technology Curated by ChEMBL | Assay Description Inhibition of HIV1 reverse transcriptase K103N mutant by HeLa-MAGI assay | Bioorg Med Chem Lett 18: 1181-94 (2008) Article DOI: 10.1016/j.bmcl.2007.11.134 BindingDB Entry DOI: 10.7270/Q2NS0XPK | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| HIV-1 Reverse Transcriptase Mutant (K103N) (Human immunodeficiency virus type 1) | BDBM5026 (3-substituted thiazolidene deriv. 17a | N-[(2Z)-5-...) | PDB MMDB B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 1.30E+4 | n/a | n/a | n/a | n/a | 8.4 | 37 |
Yamanouchi Pharmaceutical Co. Ltd | Assay Description The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro. | Bioorg Med Chem 12: 6171-82 (2004) Article DOI: 10.1016/j.bmc.2004.08.050 BindingDB Entry DOI: 10.7270/Q23R0R24 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| HIV-1 Reverse Transcriptase Mutant (Y181C) (Human immunodeficiency virus type 1) | BDBM5026 (3-substituted thiazolidene deriv. 17a | N-[(2Z)-5-...) | PDB MMDB B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 66 | n/a | n/a | n/a | n/a | 8.4 | 37 |
Yamanouchi Pharmaceutical Co. Ltd | Assay Description The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro. | Bioorg Med Chem 12: 6171-82 (2004) Article DOI: 10.1016/j.bmc.2004.08.050 BindingDB Entry DOI: 10.7270/Q23R0R24 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Reverse Transcriptase (Human immunodeficiency virus 1) | BDBM5026 (3-substituted thiazolidene deriv. 17a | N-[(2Z)-5-...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 1.29E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Korea Institute of Science and Technology Curated by ChEMBL | Assay Description Inhibition of HIV1 reverse transcriptase K103N mutant by HeLa-MAGI assay | Bioorg Med Chem Lett 18: 1181-94 (2008) Article DOI: 10.1016/j.bmcl.2007.11.134 BindingDB Entry DOI: 10.7270/Q2NS0XPK | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| HIV-1 Reverse Transcriptase (Human immunodeficiency virus type 1) | BDBM5026 (3-substituted thiazolidene deriv. 17a | N-[(2Z)-5-...) | PDB MMDB B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 270 | n/a | n/a | n/a | n/a | 8.4 | 37 |
Yamanouchi Pharmaceutical Co. Ltd | Assay Description The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro. | Bioorg Med Chem 12: 6171-82 (2004) Article DOI: 10.1016/j.bmc.2004.08.050 BindingDB Entry DOI: 10.7270/Q23R0R24 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
